Gilead Sciences Profile

Gilead Sciences Patent Grants

Unitary pharmaceutical dosage form

Patent Number 9545414 - January 17, 2017

In accordance with this invention a novel pharmaceutical product containing efavirenz, emtricitabine and tenofovir DF are provided as a…

FXR (NR1H4) binding and activity modulating compounds

Patent Number 9539244 - January 10, 2017

The present invention relates to compounds which bind to the NR1H4 receptor (FXR) and act as agonists of FXR. The invention further relates to…

Compounds for the treatment of HIV

Patent Number 9540343 - January 10, 2017

The invention provides compounds of formula (I): or a salt thereof as described herein. The invention also provides pharmaceutical…

Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections

Patent Number 9533000 - January 3, 2017

A method and a composition for treatment of pulmonary bacterial infections caused by gram-negative bacteria suitable for treatment of…

Polycyclic-carbamoylpyridone compounds and their pharmaceutical use

Patent Number 9522912 - December 20, 2016

Compounds for use in the treatment of human immunodeficiency virus (HIV) infection are disclosed. The compounds have the following Formula…

Gilead Sciences Patent Applications

SOLID FORMS OF AN ASK1 INHIBITOR

Application Number 20160280683 - September 29, 2016

Crystalline forms of 5-(4-cyclopropyl-1H-imidazol-1-yl)-N-(6-(4-isopropyl-4H-1,2,4-triazol-3-yl)pyridin-2-yl)-2-fluoro-4-methylbenzamide…

Processes for preparing ASK1 inhibitors

Application Number 20160244430 - August 25, 2016

The present disclosure provides processes for the preparation of a compound of formula: which exhibits apoptosis signal-regulating kinase…

TANK-BINDING KINASE INHIBITOR COMPOUNDS

Application Number 20160096827 - April 7, 2016

Compounds having the following formula (I) and methods of their use and preparation are disclosed:

BENZIMIDAZOLE DERIVATIVES AS BROMODOMAIN INHIBITORS

Application Number 20160075695 - March 17, 2016

This application relates to chemical compounds which may act as inhibitors of, or which may otherwise modulate the activity of, a…

MODULATORS OF PHARMACOKINETIC PROPERTIES OF THERAPEUTICS

Application Number 20160067360 - March 10, 2016

The present application provides for a compound of Formula I, or a pharmaceutically acceptable salt, solvate, and/or ester thereof,…

Gilead Sciences Federal Litigation Filings

Jean-Gabriel Bernier v. Barack Obama, et al

U.S. Court of Appeals, D.C. Circuit - September 30, 2016

GILEAD SCIENCES, INC. et al v. HETERO DRUGS LTD. et al

New Jersey District Court - August 11, 2016

GILEAD SCIENCES, INC. et al v. AUROBINDO PHARMA LTD. et al

New Jersey District Court - July 8, 2016

GILEAD SCIENCES, INC. et al v. AUROBINDO PHARMA LTD. et al

New Jersey District Court - June 23, 2016

BERNIER v. OBAMA et al There are opinions or orders for this case

District Of Columbia District Court - May 3, 2016

Gilead Sciences Federal District Court Decisions

Idenix Pharmaceuticals LLC et al v. Gilead Sciences Inc. et al

Delaware District Court - December 4, 2016

MEMORANDUM ORDER re Schinazi deposition. Signed by Judge Leonard P. Stark on 12/4/16. Associated Cases: 1:13-cv-01987-LPS, 1:14-cv-00109-LPS,…

Idenix Pharmaceuticals LLC et al v. Gilead Sciences Inc. et al

Delaware District Court - November 16, 2016

MEMORANDUM OPINION re claim construction of two disputed terms and renewed motion for summary judgment on written description. Signed by Judge…

Idenix Pharmaceuticals LLC et al v. Gilead Sciences Inc. et al

Delaware District Court - November 16, 2016

MEMORANDUM ORDER re (374 in 1:14-cv-00846-LPS, 385 in 1:13-cv-01987-LPS, 330 in 1:14-cv-00109-LPS) MOTION for Reconsideration filed by …

BERNIER v. OBAMA et al

District Of Columbia District Court - August 24, 2016

MEMORANDUM OPINION AND ORDER denying 9 Plaintiff's Motion for Preliminary Injunction. See attached Memorandum Opinion and Order for…

Gilead Sciences, Inc. v. Merck & Co, Inc. et al

California Northern District Court - August 11, 2016

ORDER REGARDING 434 GILEAD'S ENTITLEMENT TO ATTORNEYS' FEES PURSUANT TO 35 U.S.C. § 285. Signed by Judge Beth Labson Freeman…

Gilead Sciences State Court Decisions

Idenix Pharmaceuticals LLC et al v. Gilead Sciences Inc. et al

Delaware Delaware District Court - November 16, 2016

MEMORANDUM OPINION re claim construction of two disputed terms and renewed motion for summary judgment on written description. Signed by Judge…

AIDS Healthcare Foundation, Inc. v. Gilead Sciences, Inc. et al

California California Northern District Court - July 21, 2016

ORDER ENTERING FINAL JUDGMENT by Hon. William Alsup granting 109 Motion to enter judgment.(whalc1, COURT STAFF) (Filed on 7/21/2016)

AIDS Healthcare Foundation, Inc. v. Gilead Sciences, Inc. et al

California California Northern District Court - July 6, 2016

ORDER GRANTING MOTIONS TO DISMISS by Judge Alsup granting 80 Motion to Dismiss; granting 81 Motion to Dismiss; granting 83 Motion to Dismiss.…

GILEAD SCIENCES, INC. et al v. WATSON LABORATORIES, INC.

New Jersey New Jersey District Court - April 26, 2016

OPINION. Signed by Judge Renee Marie Bumb on 4/26/2016. (TH, )

Gilead Sciences, Inc. v. Merck & Co, Inc. et al

California California Northern District Court - January 11, 2016

ORDER DENYING MOTION TO COMPEL by Magistrate Judge Paul Singh Grewal, denying 156 . (psglc1S, COURT STAFF) (Filed on 1/11/2016)

Gilead Sciences Federal Appellate Court Decisions

GILEAD SCIENCES, INC. v. LEE

U.S. Court of Appeals for the Federal Circuit - February 26, 2015

GILEAD SCIENCES, INC. v. SIGMAPHARM LABS

U.S. Court of Appeals for the Federal Circuit - December 8, 2014

GILEAD SCIENCES, INC. v. SIGMAPHARM LABS

U.S. Court of Appeals for the Federal Circuit - November 19, 2014